ALC logo

ALCON INC

ALCNYSE
Earnings Nov 11US Equity
$65.43β–² $0.18 (+0.28%)
After hours Β· at close
πŸ””
Track ALC
Get earnings, price moves & breaking news on Telegram
Track
24hβ–² 0.3%
7dβ–Ό 0.2%
14dβ–Ό 3.4%
30dβ–Ό 9.2%
ytdβ–Ό 16.9%
1yβ–Ό 11.7%
🏦Market Cap
$32.70B
Mid Cap
πŸ“ˆRevenue Growth (YoY)
+8.3%
Slowing
πŸ“ŠGross Margin
59.6%
Healthy
πŸ’΅FCF Margin
14.6%
Healthy
βš–οΈP/S Ratio
2.9x
Cheap
Otter Score
56
Weak

Trading Snapshot

Day Range
$65.18 – $65.75
52-Week Range
$47.80 – $68.34
Volume
$2.43B
Avg Volume
$2.26B
Shares Outstanding
499.7M
Next Earnings
Oct 30, 2026

Fundamentals Snapshot

Annual Revenue
$10.40B
Last Q Revenue
$2.82B
P/E Ratio
39.1
P/S Ratio
2.9x
EPS (TTM)
$1.30
Dividend Yield
0.54%
Dilution (1yr)
βˆ’1.0%

Why Investors Own ALC

  • βœ“High-growth profile β€” revenue up -7.6% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 58% gross margin and 26% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

ALC logo

ALCON INC

ALC
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$10.4Bβ–² +4.9% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
55.2%β–Ό βˆ’0.7% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
$1.4Bβ–Ό βˆ’3.8% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
$1.6Bβ–² +14.3% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
492.3Mβ–Ό βˆ’1.0% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
βˆ’$3.7Bβ–Ό βˆ’$267M YoY
StockOtter Β· stockotter.space

About ALCON INC

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. The company’s cataract products include Unity CS, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS biometer, SMARTCATARACT health platform, NGENUITY 3D visualization system, LuxOR surgical ophthalmic microscope, and ORA system for intra-operative measurements; ADI cloud-based platform; and implantable products, including monofocal, Toric, and Presbyopia-Correcting IOLs, as well as delivery systems, such as AutonoMe and UltraSert. In addition, it provides Custom Pak surgical procedure packs vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, Grieshaber, MIVS instruments; scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit probes; and refractive surgery products, including WaveLight and Contoura Vision used for LASIK refractive procedure. Further, the company offers daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Weak
56/100

Analyst Price Target

β“˜
Average Target
$86.57
β–² +32.3% Upside
High Target$107.22
Low Target$76.42
Based on 36 analysts

Latest News & Updates